Education
About Us
Working with TipRanks
Follow Us
West Pharmaceutical Services, Inc. (WST)
:WST
RESEARCH TOOLSreports
WST Stock Chart & Stats
Day’s Range― - ―
52-Week Range$187.43 - $352.33
Previous CloseN/A
Volume102.64K
Average Volume (3M)806.26K
Market Cap
$17.18B
Enterprise Value$15.66B
Total Cash (Recent Filing)$509.70M
Total Debt (Recent Filing)$303.30M
Price to Earnings (P/E)35.8
Beta0.83
Next Earnings
Oct 23, 2025EPS Estimate
1.68Next Dividend Ex-Date
Nov 12, 2025Dividend Yield0.35%
Share Statistics
EPS (TTM)1.84
Shares Outstanding71,907,326
10 Day Avg. Volume1,124,490
30 Day Avg. Volume806,261
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.91
Enterprise Value/Revenue5.29
Enterprise Value/Gross Profit15.00
Enterprise Value/Ebitda20.62
Forecast
1Y Price Target
$308.75Price Target Upside29.26% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Bulls Say, Bears Say
Bulls Say
Guidance And ForecastGuidance for 2025 was raised with expectations of increased total reported revenue and organic growth.
Revenue And Earnings GrowthWest Pharmaceutical Services reported revenue of $766.5 million, surpassing both internal and consensus estimates.
Bears Say
Operating Margin And ProfitabilityOperating profit margin contracted to 15.3% from 17.7%, impacted by restructuring charges and a shift in product mix away from higher-margin components.
Product MarginsThe recent SmartDose launch has resulted in negative gross margins, which management must address to achieve long-term revenue growth and margin targets.
West Pharmaceutical Services News
WST FAQ
What was West Pharmaceutical Services, Inc.’s price range in the past 12 months?
West Pharmaceutical Services, Inc. lowest stock price was $187.43 and its highest was $352.33 in the past 12 months.
What is West Pharmaceutical Services, Inc.’s market cap?
West Pharmaceutical Services, Inc.’s market cap is $17.18B.
When is West Pharmaceutical Services, Inc.’s upcoming earnings report date?
West Pharmaceutical Services, Inc.’s upcoming earnings report date is Oct 23, 2025 which is in 76 days.
How were West Pharmaceutical Services, Inc.’s earnings last quarter?
West Pharmaceutical Services, Inc. released its earnings results on Jul 24, 2025. The company reported $1.84 earnings per share for the quarter, beating the consensus estimate of $1.509 by $0.331.
Is West Pharmaceutical Services, Inc. overvalued?
According to Wall Street analysts West Pharmaceutical Services, Inc.’s price is currently Undervalued.
Does West Pharmaceutical Services, Inc. pay dividends?
West Pharmaceutical Services, Inc. pays a Quarterly dividend of $0.22 which represents an annual dividend yield of 0.35%. See more information on West Pharmaceutical Services, Inc. dividends here
What is West Pharmaceutical Services, Inc.’s EPS estimate?
West Pharmaceutical Services, Inc.’s EPS estimate is 1.68.
How many shares outstanding does West Pharmaceutical Services, Inc. have?
West Pharmaceutical Services, Inc. has 71,907,326 shares outstanding.
What happened to West Pharmaceutical Services, Inc.’s price movement after its last earnings report?
West Pharmaceutical Services, Inc. reported an EPS of $1.84 in its last earnings report, beating expectations of $1.509. Following the earnings report the stock price went up 22.785%.
Which hedge fund is a major shareholder of West Pharmaceutical Services, Inc.?
Currently, no hedge funds are holding shares in WST
West Pharmaceutical Services Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$308.75 (29.26% Upside)
$308.75 (29.26% Upside)
Blogger Sentiment
Bullish
WST Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 521.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.8%
Last 30 Days ▲ 15.7%
Last 30 Days ▲ 15.7%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.82%
12-Months-Change
Fundamentals
Return on Equity
17.72%
Trailing 12-Months
Asset Growth
13.28%
Trailing 12-Months
Company Description
West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. is a leading manufacturer in the pharmaceutical industry, specializing in the design and production of innovative delivery systems, components, and solutions for injectable drug administration. Founded in 1923 and headquartered in Exton, Pennsylvania, the company operates across multiple sectors, including healthcare, pharmaceuticals, and biotechnology. West Pharmaceutical Services is renowned for its high-quality components and systems that support the safe and efficient delivery of drugs and biologics.
WST Company Deck
WST Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected strong performance in key growth areas like HVP components and delivery devices, leading to upward revisions in revenue and EPS guidance for 2025. However, challenges such as slow growth in Standard Products, persistent destocking in generics, and tariff uncertainties remain concerns.View all WST earnings summariesWST Revenue Breakdown
80.69% Proprietary Products
19.31% Contract-Manufactured Products
0.00% Intersegment sales elimination
WST Stock 12 Month Forecast
Average Price Target
$308.75
▲(29.26% Upside)
Technical Analysis
Ownership Overview
0.57% Insiders
28.76% Mutual Funds
1.91% Other Institutional Investors
38.18% Public Companies and
Individual Investors